| Literature DB >> 30736800 |
Megan L Curran1, Emma E Martin2, Erin C Thomas2, Rashmi Singh2, Saima Armana2, Asnia Kauser2, Eesha A Zaheer2, David D Sherry3.
Abstract
BACKGROUND: Of 37 pediatric rheumatology fellowship training programs in the United States, many have three or fewer fellows at a given time, making large-scale assessment of fellow performance difficult. An objective structured clinical examination (OSCE) is a scenario-based simulation method that assesses individual performance, thus indirectly measuring training program effectiveness. This study describes the development and implementation of two national pediatric rheumatology OSCEs and methods used for programmatic improvement.Entities:
Keywords: Assessment; Fellowship education; Medical education; Objective structured clinical examination; Program evaluation; Simulation
Mesh:
Year: 2019 PMID: 30736800 PMCID: PMC6367759 DOI: 10.1186/s12969-019-0308-7
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
2009 and 2011 Pediatric Rheumatology Objective Structured Clinical Examination Scenario Descriptions
| Scenario Number | Description | 2009 Assessors | 2011 Assessors |
|---|---|---|---|
| 1 | Inform a parent of a child recently diagnosed with lupus about risks and benefits of glucocorticoid treatment | pediatric rheumatologist, parenta | pediatric rheumatologist, parenta |
| 2 | Prepare a joint injection for a patient with juvenile arthritis without a nurse present | pediatric rheumatologist | scenario not performed |
| 3 | Perform joint aspiration and injection using an orange model (in 2009, scenario included consenting parent for the procedure) | pediatric rheumatologist, parenta, patienta | pediatric rheumatologist, nurseb, parenta, patienta |
| 4 | Perform a complete musculoskeletal exam on a patient with juvenile arthritis | pediatric rheumatologist, parenta, patienta | pediatric rheumatologist, parenta, patienta |
| 5 | Discuss a child’s diagnosis of juvenile dermatomyositis with a parent | pediatric rheumatologist, parenta | pediatric rheumatologist, parenta |
| 6 | Give a brief lecture about juvenile idiopathic arthritis to medical trainees | pediatric rheumatologist | pediatric rheumatologist, medical studentc |
| 7 | Write an appeal letter to an insurance company supporting the use of a biologic drug for a juvenile arthritis patient | pediatric rheumatologist | scenario not performed |
| 8 | Complete multiple-choice questions about gait and its diagnostic significance | scenario not performed | No assessors |
| 9 | Practice delivering bad news to parents of a child with joint pain determined to have cancer | scenario not performed | pediatric rheumatologist, parenta |
aRoles of parents and patients were played by volunteers, either true patients with pediatric rheumatic diseases, parents of children with rheumatic diseases or lay-person adults. They were not formally trained standardized patient actors
bVolunteer registered nurses from the pediatric rheumatology clinic
cVolunteer medical students recruited by email
Number of Cases Evaluating ACGME Competency Elements in the 2009 and 2011 Pediatric Rheumatology Objective Structured Clinical Examinations
| ACGME Competency | Competency Elements | Number of Cases 2009 | Number of Cases 2011 |
|---|---|---|---|
| Patient Care: Procedural | Joint injection | 2 | 1 |
| Patient Care: Non-Procedural | Musculoskeletal exam | 1 | 1 |
| Develop management plans | 2 | 3 | |
| Diagnostic decisions | 1 | 3 | |
| Professionalism | Informed consent | 2 | 2 |
| Demonstrate empathy | 4 | 5 | |
| Interpersonal Communication | Relationship development | 4 | 5 |
| Teaching skills | 1 | 1 | |
| Systems-Based Practice | Letter to insurance company | 1 | 0 |
| Medical Knowledge | Medication side effects | 2 | 3 |
| Disease knowledge | 3 | 3 | |
| Practice-Based Learning | Patient education | 4 | 5 |
| Resident education | 1 | 1 |
Average Fellow Performance Ratings by Pediatric Rheumatologist Assessors Using a Five-Point Scale (0–4)* by Scenario
| Scenario | Overall Performance | Professionalism | Communication | |||
|---|---|---|---|---|---|---|
| 2009a | 2011 | 2009a | 2011 | 2009a | 2011 | |
| 1: Glucocorticoid explanation | 3.08 | 2.68 | 2.75 | 3.74 | 2.69 | 3.21 |
| 2: Joint injection preparation | 2.72 | N/A | N/A | N/A | N/A | N/A |
| 3: Joint injection simulation | 2.59 | 3.00 | 3.24 | 3.42 | 2.98 | 3.11 |
| 4: Musculoskeletal exam | 2.67 | 3.21 | 3.32 | 3.68 | 3.23 | 3.37 |
| 5: Dermatomyositis diagnosis discussion | 3.13 | 2.61 | 3.42 | 3.17 | 3.14 | 2.89 |
| 6: Juvenile arthritis lecture | 3.02 | 2.82 | N/A | N/A | N/A | N/A |
| 7: Insurance appeal | 2.61 | N/A | N/A | N/A | N/A | N/A |
| 8: Gait analysis | N/A | Score not averaged | N/A | Score not averaged | N/A | Score not averaged |
| 9: Bad news delivery | N/A | 2.89 | N/A | 3.39 | N/A | 2.72 |
a2009 VAS scores (0–100) with anchors of poor and excellent were scaled to 2011 five-point scale from 0-poor, novice, intermediate, advanced, expert-4
Selected Results from Scenario Checklists in the 2009 and 2011 Pediatric Rheumatology Objective Structured Clinical Examinations
| Scenario | 2009 | 2011 |
|---|---|---|
| 1: Gluco-corticoid explanation | 10/21 did not mention risk of adrenal suppression; 6/21 did not say the risk-benefit ratio favored taking steroids | 16/19 did not mention risk of adrenal suppression; 4/19 did not say the risk-benefit ratio favored taking steroids |
| 2: Joint injection preparation | 11/21 did not prepare the injection sterilely; 12/21 did not buffer the lidocaine | Scenario not used |
| 3: Joint injection explanation and simulation | All fellows were respectful of parent’s concerns; 13/21 did not mention skin hypopigmentation as a side effect | All fellows were respectful of parent’s concerns; 12/19 did not mention skin hypopigmentation as a side effect |
| 4: Musculo-skeletal exam | Of all assessed joints, none was examined by all 21 fellows; 7/21 fellows did not check forefoot | The wrist was the only joint examined by all 19 fellows; 8/19 fellows did not check forefoot |
| 5: Dermato-myositis diagnosis discussion | 11/21 did not mention possibility of abdominal pain; 14/21 did not mention possible emotional consequences of JDM | 12/18 did not mention possibility of abdominal pain; 14/18 did not mention safety precautions necessary due to muscle weakness |
| 6: Juvenile arthritis lecture | 9/21 did not mention limb growth abnormalities; 11/21 did not mention jaw disease related to oligoarticular juvenile arthritis | 10/19 did not mention limb growth abnormalities; 13/19 did not mention jaw disease related to oligoarticular juvenile arthritis |
| 7: Insurance appeal | 10/21 did not cite a source correctly for the letter; 10/21 did not describe patient consequences of denied treatment | Scenario not used |
| 8: Gait analysis | Scenario not used | Not scored |
| 9: Bad news delivery | Scenario not used | All 18 fellows were respectful of the parent; 11/18 did not ask how much information the parent wanted to know about cancer |
Comparison of mean overall performance scores by training year using student’s t-test
| PROSCE Year | Training Year | Mean Overall Performance Scorea | SD | Comparison | |
|---|---|---|---|---|---|
| 2009 | 1 ( | 2.69 | 0.40 | Years 1 to 2 | 0.125 |
| 2 (n = 8) | 2.95 | 0.43 | Years 2 to 3 | 0.134 | |
| 3+ ( | 3.19 | 0.30 | Years 1 to 3 | 0.016 | |
| 2011 | 1 ( | 2.82 | 0.48 | Years 1 to 2 | 0.056 |
| 2 ( | 3.22 | 0.25 | Years 2 to 3 | 0.460 | |
| 3 (n = 5) | 3.24 | 0.39 | Years 1 to 3 | 0.074 |
a2009 VAS scores (0–100) from poor and excellent were scaled to 2011 five-point scale from 0-poor, novice, intermediate, advanced, expert-4